Greater Control Over Drug Supply Management Helps Sponsors Reduce Costs and Carbon Footprint

更好地控制药品供应管理有助于赞助商降低成本和碳足迹

PHILADELPHIA, Oct. 12, 2023 /PRNewswire/ -- Suvoda LLC, a global clinical trial technology company that specializes in complex studies in therapeutic areas like oncology, central nervous system (CNS), and rare disease, announced a new Advanced Drug Optimization feature as part of its latest Interactive Response Technology (IRT) release.

费城，2023年10月12日/PRNewswire/-Suvoda LLC是一家全球临床试验技术公司，专门从事肿瘤学，中枢神经系统（CNS）和罕见病等治疗领域的复杂研究，宣布了一项新的先进药物优化功能作为其最新交互式响应技术（IRT）版本的一部分。

This new functionality offers sponsors of clinical drug trials improved drug supply management, delivering cost savings and helping companies to reduce their carbon footprint..

这项新功能为临床药物试验的赞助商提供了改进的药物供应管理，节省成本并帮助公司减少碳足迹。。

Traditionally, drug supply strategies have relied on static quantities of initial drug shipments and buffers, often leading to excessive orders to ensure enough medication is available during a trial. Buffers, a common tool for ensuring adequate medication supply at sites, create average upper and lower limits for medication stock at all trial sites and automatically trigger medication orders if supplies hit the low limit..

传统上，药物供应策略依赖于初始药物装运和缓冲液的静态数量，通常导致过度订单以确保在试验期间有足够的药物可用。缓冲液是确保现场充足药物供应的常用工具，可在所有试验场所创建药物库存的平均上限和下限，并在供应达到下限时自动触发药物订单。。

Suvoda's Advanced Drug Optimization feature is an innovative approach that allows drug supply managers to fine-tune their supply strategies by creating 'advanced rules' that factor in enrollment variables, such as participant weight, projected screen failure rates, and treatment ratios. The result is more granular and dynamic supply forecasts, which may translate to significant cost savings.

Suvoda的Advanced Drug Optimization功能是一种创新方法，它允许药品供应经理通过创建影响入学变量的“高级规则”（如参与者体重，预计屏幕故障率和治疗比率）来微调他们的供应策略。结果是更加细化和动态的供应预测，这可能转化为显着的成本节约。

Further, by enabling more precise drug optimization, sponsors may cut back on packaging and shipping, which translates to a better carbon footprint score in support of corporate sustainability goals. .

此外，通过实现更精确的药物优化，赞助商可以减少包装和运输，这可以转化为更好的碳足迹分数，以支持企业可持续发展目标。 .

'Suvoda's new enhancement is an example of how we listen to the needs of our customers and deliver tools that help our sponsors and partners,' said Lisa Li, director of IRT product management with Suvoda. 'We heard from drug supply managers that they were concerned about the impact of drug oversupply across the entire supply chain, including raw materials, manufacturing, storage, shipping, and packing materials.

“Suvoda的新改进就是我们如何倾听客户需求并提供帮助我们的赞助商和合作伙伴的工具的一个例子，”Suvoda IRT产品管理总监Lisa Li说我们从药品供应经理那里听说，他们担心药品供应过剩对整个供应链的影响，包括原材料，制造，储存，运输和包装材料。

Helping study managers fine-tune supply can maximize trial resources and increase efficiencies.'.

帮助学习管理者微调供应可以最大限度地利用试验资源并提高效率。

The Advance Drug Optimization feature aligns with Suvoda's mission to deliver purpose-built e-clinical solutions that give sponsors command over trials with complex drug supply management needs. Examples include trials with patient cohorts featuring large variations that can affect enrollment dosage, such as pediatric trials.

Advance药物优化功能与Suvoda提供专用电子临床解决方案的使命相一致，该解决方案使赞助商能够指挥具有复杂药物供应管理需求的试验。例子包括具有可能影响登记剂量的大变化的患者队列的试验，例如儿科试验。

Other trial designs that could benefit from this functionality include those involving high-cost drugs, high screen failure rates, and large trials with numerous subjects per site. .

可以从该功能中受益的其他试验设计包括涉及高成本药物，高屏幕失败率以及每个站点具有多个受试者的大型试验的试验设计。 .

This enhancement also strengthens Suvoda's partnership with N-SIDE, a deep tech company that empowers organizations in the clinical trials industry to make better decisions and optimize the use of critical resources. Together, Suvoda and N-SIDE seamlessly deliver integrated forecasting and supply-chain optimization to help studies reduce drug supply cost and wastage..

这一改进还加强了Suvoda与N-SIDE的合作关系，N-SIDE是一家深度科技公司，使临床试验行业的组织能够做出更好的决策并优化关键资源的使用。Suvoda和N端一起无缝地提供集成的预测和供应链优化，以帮助研究降低药品供应成本和浪费。。

'As a Suvoda partner, we are excited about this feature. We've quantified the impact of this advanced functionality on hundreds of trials, and it generally reduces drug needs by more than 10 percent,' said Amaury Jeandrain, vice president of strategy, life sciences, for N-SIDE. 'Suvoda has always been committed to innovating on drug supply to ensure that its IRT solution continues to give sponsors the greatest amount of visibility and control possible.

“作为Suvoda的合作伙伴，我们对此功能感到兴奋。生命科学战略副总裁Amaury Jeandrain说，我们已经量化了这一高级功能对数百项试验的影响，并且通常将药物需求减少10%以上Suvoda一直致力于药物供应方面的创新，以确保其IRT解决方案继续为赞助商提供尽可能多的可见性和控制。

And, Advanced Drug Optimization gives us more tools to help our joint customers meet their drug supply needs in ways that better support their clinical trial and organizational goals.'.

而且，先进的药物优化为我们提供了更多工具，以更好地支持其临床试验和组织目标的方式帮助我们的联合客户满足他们的药物供应需求。

Learn more about Suvoda IRT for clinical trials.

了解更多关于Suvoda IRT的临床试验。

About SuvodaSuvoda is a global clinical trial technology company specializing in complex, life-sustaining studies in therapeutic areas like oncology, central nervous system (CNS), and rare disease. Founded in 2013 by experts in eClinical technologies, Suvoda empowers clinical trial professionals to manage the most urgent moments in the most urgent trials through advanced software solutions delivered on a single platform.

关于SuvodaSuvoda是一家全球临床试验技术公司，专门从事肿瘤学，中枢神经系统（CNS）和罕见疾病等治疗领域的复杂，维持生命的研究。Suvoda成立于2013年，由临床技术专家创立，通过在单一平台上提供的先进软件解决方案，使临床试验专业人员能够管理最紧急试验中的最紧迫时刻。

Headquartered outside Philadelphia, Suvoda also maintains offices in Portland, OR, Barcelona, Spain, Bucharest and Iasi, Romania, and Tokyo, Japan. The company's Net Promoter Score (NPS) consistently exceeds the technology industry average, contributing to the company being selected by trial sponsors and CROs to support more than 1,000 trials across 80 countries.

Suvoda总部设在费城以外，还在俄勒冈州波特兰，西班牙巴塞罗那，布加勒斯特和罗马尼亚雅西以及日本东京设有办事处。该公司的净启动子得分（NPS）始终超过技术行业平均水平，有助于该公司被试验赞助商和CRO选中，以支持80个国家的1000多项试验。

To learn more, visit suvoda.com and follow Suvoda on LinkedIn. .

要了解更多信息，请访问suvoda.com并在LinkedIn上关注suvoda。 .

For information contact:

有关信息，请联系：

Mara Conklin, (847) 340-6823[email protected]

Mara Conklin，（847）340-6823[电子邮件保护]

Kathy Zoeller, (312) 485-2422kathy@mattsonpr.com

凯西·佐勒，（312）485-2422kathy@mattsonpr.com

Logo - https://mma.prnewswire.com/media/1759317/Suvoda_Logo.jpg

徽标-https://mma.prnewswire.com/media/1759317/Suvoda_Logo.jpg

SOURCE Suvoda LLC

SOURCE Suvoda LLC